the Comparison Efficacy of Azithromycin With Doxycycline in the Treatment of Acne Vulgaris
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00419848 |
Recruitment Status : Unknown
Verified January 2008 by Shahid Beheshti University of Medical Sciences.
Recruitment status was: Recruiting
First Posted : January 9, 2007
Last Update Posted : January 29, 2008
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Acne | Drug: Doxycycline Drug: Azithromycin | Phase 2 |
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 100 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Treatment |
Official Title: | the Comparison Efficacy of Azithromycin With Doxycycline in the Treatment of Acne Vulgaris |
Study Start Date : | August 2006 |
Estimated Primary Completion Date : | January 2008 |
Estimated Study Completion Date : | February 2008 |

Arm | Intervention/treatment |
---|---|
Experimental: 1 |
Drug: Azithromycin
Azithromycin: Cap 250 mg- 500 mg single dose/daily - 3 times per week
Other Name: kimidarou |
Active Comparator: 2 |
Drug: Doxycycline
Cap 100mg- 100mg/daily
Other Name: Razak lab |
- change in acne lesions [ Time Frame: 12 weeks ]
- global response rates, patient's own assessment, side effects and compliance [ Time Frame: 12 weeks ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 30 Years (Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Between 18 to 30 year old
- Moderate facial Acne(At least 10 inflammatory lesions with maximum 3 nodules and pseudocysts
Exclusion Criteria:
- Pregnancy
- Breast Feeding
- Acne Fulminant
- Acne conglobate
- Isotretinoin therapy within past 6 months
- topical treatment in last 2 weeks
- use of systemic antibiotic in the last month
- Hyperandrogenism symptoms
- Menstrual irregularity

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00419848
Contact: Parviz Toossi, M.D. | 98-21-22744393 ext 5 | src@sbmu.ac.ir |
Iran, Islamic Republic of | |
Shaheed Beheshti Medical University, Skin research center | Recruiting |
Tehran, Iran, Islamic Republic of, 198994148 |
Study Chair: | Parviz Toossi, M.D. | Skin Research Center | |
Principal Investigator: | Hamideh Moravvej, M.D. | Skin Research Center | |
Principal Investigator: | Akbar Mousazadeh halim, M.D. | Skin Research Center |
Responsible Party: | Skin research center, Shaheed Beheshti Medical unversity |
ClinicalTrials.gov Identifier: | NCT00419848 |
Other Study ID Numbers: |
src-hmj-1385 |
First Posted: | January 9, 2007 Key Record Dates |
Last Update Posted: | January 29, 2008 |
Last Verified: | January 2008 |
Acne Azithromycin Doxycycline |
Acne Vulgaris Acneiform Eruptions Skin Diseases Sebaceous Gland Diseases Azithromycin Doxycycline |
Anti-Bacterial Agents Anti-Infective Agents Antimalarials Antiprotozoal Agents Antiparasitic Agents |